CORC  > 复旦大学上海医学院
A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients
Wang, Tao; Wu, Biao; Hui, Xichun; Liu, Jinping; Zhang, Tao; Li, Funian; Sun, Bing; Cai, Li; Li, Xinzheng; Chen, Zhiyue
刊名ANNALS OF TRANSLATIONAL MEDICINE
2019
卷号7期号:9
关键词Mecapegfilgrastim efficacy safety neutropenia chemotherapy breast cancer
ISSN号2305-5839
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3598162
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Wang, Tao,Wu, Biao,Hui, Xichun,et al. A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients[J]. ANNALS OF TRANSLATIONAL MEDICINE,2019,7(9).
APA Wang, Tao.,Wu, Biao.,Hui, Xichun.,Liu, Jinping.,Zhang, Tao.,...&Jiang, Zefei.(2019).A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients.ANNALS OF TRANSLATIONAL MEDICINE,7(9).
MLA Wang, Tao,et al."A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients".ANNALS OF TRANSLATIONAL MEDICINE 7.9(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace